Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | N/A | -18,040 | N/A | N/A |
| Depreciation Amortization | 0 | N/A | 210 | N/A | N/A |
| Other Working Capital | 0 | N/A | -240 | N/A | N/A |
| Other Operating Activity | -6,164 | -3,476 | 3,360 | -13,330 | -10,430 |
| Operating Cash Flow | $-6,164 | $-3,476 | $-14,710 | $-13,330 | $-10,430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -91 | -7 | -240 | -140 | -50 |
| Purchase Of Investment | -110 | -36 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,440 |
| Investing Cash Flow | $-201 | $-43 | $-240 | $-140 | $-1,490 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,964 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -88 | 0 | 12,750 | 12,640 | 12,610 |
| Financing Cash Flow | $1,876 | $N/A | $12,750 | $12,640 | $12,610 |
| Exchange Rate Effect | 29 | -148 | -370 | -540 | 10 |
| Beginning Cash Position | 13,653 | 13,820 | 15,860 | 15,730 | 15,690 |
| End Cash Position | 9,192 | 10,154 | 13,270 | 14,350 | 16,390 |
| Net Cash Flow | $-4,460 | $-3,666 | $-2,590 | $-1,370 | $700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,164 | -3,476 | -14,710 | -13,330 | -10,430 |
| Capital Expenditure | -91 | -7 | N/A | N/A | N/A |
| Free Cash Flow | -6,255 | -3,483 | -14,710 | -13,330 | -10,430 |